Drug recall · March 15, 2017
Mirtazapine Tablets recall
Why: Presence of Foreign Tablets/Capsules; possibility of Glipizide 10 mg tablets commingled
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Mirtazapine Tablets, USP, 45 mg. Rx only, 100 Tablets (10 X 10). Manufactured by: Mylan Pharmaceuticals Inc, Morgantown, WV ---NDC 51079-088-20
- Lots / codes
Batch #3083289; Exp. Date 12/2018
- Quantity
- 58 UD100 Unit Dose Blister Cards of 10 (10 cards of 10 tablets each)
- Company
- Mylan Institutional, Inc. (d.b.a. UDL Laboratories), Rockford, IL
- Distribution
- Nationwide
- Initiated
- January 27, 2017 · Voluntary: Firm initiated
- Classified
- March 8, 2017
- Reported
- March 15, 2017
- Ended
- March 15, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Mirtazapine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.